ERBB2 and breast cancer: Our binary logistic regression analysis reveal that the phenotypic subtype was the unique associated factor in models that included age, stage, and chemotherapy regimens, and we found that patients with HER2-positive breast cancer, particularly TNBC, had higher pCR rates than HR-positive/HER2-negative patients.